A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Stage III Breast Cancer
Interventions: DRUG: docetaxel, epirubicin and cyclophosphamide|DRUG: docetaxel, epirubicin and cyclophosphamide plus endostar
Sponsor: Hebei Medical University Fourth Hospital